当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2018年第12期
编号:13229839
ANO1在头颈部鳞癌中的表达及与患者预后的相关性(4)
http://www.100md.com 2018年4月25日 《中国医药导报》 2018年第12期
     [12] Van Waes C,Musbahi O. Genomics and advances towards precision medicine for head and neck squamous cell carcinoma [J]. Laryngoscope Investig Otolaryngol,2017,2(5):310-319.

    [13] Oh U,Jung J. Cellular functions of TMEM16/anoctamin [J]. Pflugers Arch,2016,468(3):443-453.

    [14] 侯毅鞠,许会静,张雲乔,等.钙激活氯通道ANO1在小鼠心肌细胞的表达及其功能鉴定[J].中国病理生理杂志,2015(3):539-542.

    [15] Wu H,Guan S,Sun M,et al. Ano1/TMEM16A Overexpression Is Associated with Good Prognosis in PR-Positive or HER2-Negative Breast Cancer Patients following Tamoxifen Treatment [J]. PLoS One,2015,10(5):e126128.

    [16] Shang L,Hao JJ,Zhao XK,et al. ANO1 protein as a potential biomarker for esophageal cancer prognosis and precancerous lesion development prediction [J]. Oncotarget,2016,7(17):24374-24382.

    [17] Liu W,Lu M,Liu B,et al. Inhibition of Ca(2+)-activated Cl(-) channel ANO1/TMEM16A expression suppresses tumor growth and invasiveness in human prostate carcinoma [J]. Cancer Lett,2012,326(1):41-51.

    [18] Jia L,Liu W,Guan L,et al. Inhibition of Calcium-Activated Chloride Channel ANO1/TMEM16A Suppresses Tumor Growth and Invasion in Human Lung Cancer [J]. PLoS One,2015,10(8):e136584.

    [19] Wang H,Zou L,Ma K,et al. Cell-specific mechanisms of TMEM16A Ca(2+)-activated chloride channel in cancer [J]. Mol Cancer,2017,16(1):152.

    (收稿日期:2018-03-10 本文編辑:任 念), http://www.100md.com(周宏 李文平 裴斐 吴刚)
上一页1 2 3 4